Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Wickland

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Prevention Research (Philadelphia, Pa.)|August 6, 2020
Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American WomenJoshua W Ogony, Derek C Radisky, Kathryn J Ruddy, et al.
Frontiers in Immunology|June 22, 2026
Identification of tumor-associated antigens with multi-cancer therapeutic potentialDaniel P Wickland, Erik Jessen, Asha Nair, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Plos One|April 16, 2021
Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studiesDaniel P Wickland, Yingxue Ren, Jason P Sinnwell, et al.
Neuro-Oncology|June 15, 2026
Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastomaDiogo Moniz Garcia, Wan-Hsin Lin, Daniel P Wickland, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Medicine|June 16, 2023
The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional studyBillie J Matchett, Sarah J Lincoln, Matt Baker, et al.
JAMA Neurology|April 15, 2024
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer DiseaseNaomi Kouri, Isabelle Frankenhauser, Zhongwei Peng, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Prevention Research (Philadelphia, Pa.)|August 6, 2020
Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American WomenJoshua W Ogony, Derek C Radisky, Kathryn J Ruddy, et al.
Frontiers in Immunology|June 22, 2026
Identification of tumor-associated antigens with multi-cancer therapeutic potentialDaniel P Wickland, Erik Jessen, Asha Nair, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Plos One|April 16, 2021
Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studiesDaniel P Wickland, Yingxue Ren, Jason P Sinnwell, et al.
Neuro-Oncology|June 15, 2026
Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastomaDiogo Moniz Garcia, Wan-Hsin Lin, Daniel P Wickland, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
Medicine|June 16, 2023
The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional studyBillie J Matchett, Sarah J Lincoln, Matt Baker, et al.
JAMA Neurology|April 15, 2024
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer DiseaseNaomi Kouri, Isabelle Frankenhauser, Zhongwei Peng, et al.
Pageof 2